Stereotactic laser ablation of high-grade gliomas

Neurosurgical Focus

Volumn 37, Issue 6, 2014, Pages

  Hawasli, Ammar H ^a   Kim, Albert H ^a,b   Dunn, Gavin P ^a,b   Tran, David D ^b   Leuthardt, Eric C ^a,c  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Glioblastoma; Glioma; Laser ablation; Laser interstitial thermal therapy; Minimally invasive surgery

Indexed keywords

BRAIN NEOPLASMS; GLIOMA; HUMAN; LOW LEVEL LASER THERAPY; PROCEDURES; STEREOTACTIC PROCEDURE;

BRAIN NEOPLASMS; GLIOMA; HUMANS; LASER THERAPY; STEREOTAXIC TECHNIQUES;

EID: 84916928684     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2014.9.FOCUS14471     Document Type: Article

References (82)

1. Ammirati M, Galicich JH, Arbit E, Liao Y: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21:607-614, 1987
2. Anzai Y, Lufkin R, DeSalles A, Hamilton DR, Farahani K, Black KL: Preliminary experience with MR-guided thermal ablation of brain tumors. AJNR Am J Neuroradiol 16:39-52, 1995
3. Ascher PW, Justich E, Schröttner O: Interstitial thermotherapy of central brain tumors with the Nd:YAG laser under real-time monitoring by MRI. J Clin Laser Med Surg 9:79-83, 1991
4. Ascher PW, Justich E, Schröttner O: A new surgical but less invasive treatment of central brain tumours. Preliminary report. Acta Neurochir Suppl (Wien) 52:78-80, 1991
5. Barker FG II, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, et al: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709-723, 1998
6. Bettag M, Ulrich F, Schober R, Fürst G, Langen KJ, Sabel M, et al: Stereotactic laser therapy in cerebral gliomas. Acta Neurochir Suppl (Wien) 52:81-83, 1991
7. Bettag M, Ulrich F, Schober R, Hessel S, Sabel M: Experimental and first clinical results of Nd:YAG laser-induced hyperthermia in brain tumours, in Waidelich W, Waidelich R, Hofstetter A (eds): Laser in Medicine. Berlin: Springer-Verlag, 1992, pp 210-213
8. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91:2076-2080, 1994
9. Brandes AA, Tosoni A, Cavallo G, Bertorelle R, Gioia V, Franceschi E, et al: Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO). Br J Cancer 95:1155-1160, 2006
10. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008-1012, 1995
11. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, et al: A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495-504, 2005
12. Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, et al: Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer 101:817-824, 2004
13. Carpentier A, Chauvet D, Reina V, Beccaria K, Leclerq D, Mc-Nichols RJ, et al: MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas. Lasers Surg Med 44:361-368, 2012
14. Central Brain Tumor Registry of the United States: 2013 Fact Sheet. (http://www.cbtrus.org/factsheet/factsheet.html) [Accessed October 15, 2014]
15. Chicoine MR, Lim CC, Evans JA, Singla A, Zipfel GJ, Rich KM, et al: Implementation and preliminary clinical experience with the use of ceiling mounted mobile high field intraoperative magnetic resonance imaging between two operating rooms. Acta Neurochir Suppl 109:97-102, 2011
16. Dirks P, Bernstein M, Muller PJ, Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg 36:271-275, 1993
17. Fazeny-Dörner B, Wenzel C, Veitl M, Piribauer M, Rössler K, Dieckmann K, et al: Survival and prognostic factors of patients with unresectable glioblastoma multiforme. Anticancer Drugs 14:305-312, 2003
18. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL: Epidemiology of brain tumors. Neurol Clin 25:867-890, vii, 2007
19. Flanders VL, Gervais DA: Ablation of liver metastases: current status. J Vasc Interv Radiol 21 (8 Suppl):S214-S222, 2010
20. Fleming AB, Saltzman WM: Pharmacokinetics of the carmustine implant. Clin Pharmacokinet 41:403-419, 2002
21. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, et al: Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733-4740, 2009
22. Gong W, Wang Z, Liu N, Lin W, Wang X, Xu D, et al: Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia. Biol Pharm Bull 34:1058-1064, 2011
23. Gonzalez-Martinez J, Vadera S, Mullin J, Enatsu R, Alexopoulos AV, Patwardhan R, et al: Robot-assisted stereotactic laser ablation in medically intractable epilepsy: operative technique. Neurosurgery 10 Suppl 2:167-173, 2014
24. Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, et al: Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 16:2443-2449, 2010
25. Gulati S, Jakola AS, Nerland US, Weber C, Solheim O: The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg 76:572-579, 2011
26. Harsh GR IV, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615-621, 1987
27. Hawasli AH, Bagade S, Shimony JS, Miller-Thomas M, Leuthardt EC: Magnetic resonance imaging-guided focused laser interstitial thermal therapy for intracranial lesions: single-institution series. Neurosurgery 73:1007-1017, 2013
28. Hawasli AH, Ray WZ, Murphy RK, Dacey RG Jr, Leuthardt EC: Magnetic resonance imaging-guided focused laser interstitial thermal therapy for subinsular metastatic adenocarcinoma: technical case report. Neurosurgery 70 (2 Suppl Operative):332-338, 2012
29. Hirschberg H, Samset E, Hol PK, Tillung T, Lote K: Impact of intraoperative MRI on the surgical results for high-grade gliomas. Minim Invasive Neurosurg 48:77-84, 2005
30. Hong B, Wiese B, Bremer M, Heissler HE, Heidenreich F, Krauss JK, et al: Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme. Am J Clin Oncol 36:261-268, 2013
31. Jethwa PR, Barrese JC, Gowda A, Shetty A, Danish SF: Magnetic resonance thermometry-guided laser-induced thermal therapy for intracranial neoplasms: initial experience. Neurosurgery 71 (1 Suppl Operative):133-145, 2012
32. Kahn T, Bettag M, Ulrich F, Schwarzmaier HJ, Schober R, Fürst G, et al: MRI-guided laser-induced interstitial thermotherapy of cerebral neoplasms. J Comput Assist Tomogr 18:519-532, 1994
33. Kahn T, Harth T, Bettag M, Schwabe B, Ulrich F, Schwarzmaier HJ, et al: Preliminary experience with the application of gadolinium-DTPA before MR imaging-guided laser-induced interstitial thermotherapy of brain tumors. J Magn Reson Imaging 7:226-229, 1997
34. Kahn T, Harth T, Kiwit JC, Schwarzmaier HJ, Wald C, Mödder U: In vivo MRI thermometry using a phase-sensitive sequence: preliminary experience during MRI-guided laserinduced interstitial thermotherapy of brain tumors. J Magn Reson Imaging 8:160-164, 1998
35. Karam JA, Ahrar K, Matin SF: Ablation of kidney tumors. Surg Oncol Clin N Am 20:341-353, viii, 2011
36. Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, van Santbrink H: Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol 12:1062-1070, 2011
37. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
38. Leonardi MA, Lumenta CB: Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence. Minim Invasive Neurosurg 45:201-207, 2002
39. Leonardi MA, Lumenta CB, Gumprecht HK, von Einsiedel GH, Wilhelm T: Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR-unit. Minim Invasive Neurosurg 44:37-42, 2001
40. Lian H, Guo H, Gan W, Li X, Yan X, Wang W, et al: Cryosurgery as primary treatment for localized prostate cancer. Int Urol Nephrol 43:1089-1094, 2011
41. Lumenta CB, Leonardi MA, von Einsiedel H: Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in open MR. January 31, 2001. SPIE. (Abstract) (http://proceedings. spiedigitallibrary.org/proceeding.aspx?articleid=922481) [Accessed October 12, 2014]
42. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156-162, 2009
43. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A: Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463-470, 2009
44. Mohammadi AM, Hawasli AH, Rodriguez A, Schroeder JL, Laxton AW, Elson P, et al: The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-toaccess high-grade gliomas: a multicenter study. Cancer Med 3:971-979, 2014
45. Mohammadi AM, Schroeder JL: Laser interstitial thermal therapy in treatment of brain tumors-the NeuroBlate System. Expert Rev Med Devices 11:109-119, 2014
46. Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, et al: Five-aminolevulinic acid for fluorescenceguided resection of recurrent malignant gliomas: a phase II study. Neurosurgery 65:1070-1077, 2009
47. Nakagawa M, Matsumoto K, Higashi H, Furuta T, Ohmoto T: Acute effects of interstitial hyperthermia on normal monkey brain-magnetic resonance imaging appearance and effects on blood-brain barrier. Neurol Med Chir (Tokyo) 34:668-675, 1994
48. Niranjan A, Kondziolka D: Experimental radiosurgery models, in Chin LS, Regine WF (eds): Principles and Practice of Stereotactic Radiosurgery. New York: Springer, 2008, pp 61-67
49. Norred SE, Johnson JA: Magnetic resonance-guided laser induced thermal therapy for glioblastoma multiforme: a review. Biomed Res Int 2014:761312, 2014
50. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, et al: Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510-522, 2010
51. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, et al: Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892-6899, 2004
52. Omuro A, DeAngelis LM: Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842-1850, 2013
53. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15 (Suppl 2):ii1-ii56, 2013
54. Oztas B, Küçük M: Reversible blood-brain barrier dysfunction after intracarotid hyperthermic saline infusion. Int J Hyperthermia 14:395-401, 1998
55. Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, et al: Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28:3838-3843, 2010
56. Perry JR, Bélanger K, Mason WP, Fulton D, Kavan P, Easaw J, et al: Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. J Clin Oncol 28:2051-2057, 2010
57. Rahmathulla G, Recinos PF, Kamian K, Mohammadi AM, Ahluwalia MS, Barnett GH: MRI-guided laser interstitial thermal therapy in neuro-oncology: a review of its current clinical applications. Oncology 87:67-82, 2014
58. Reimer P, Bremer C, Horch C, Morgenroth C, Allkemper T, Schuierer G: MR-monitored LITT as a palliative concept in patients with high grade gliomas: preliminary clinical experience. J Magn Reson Imaging 8:240-244, 1998
59. Sabel M, Rommel F, Kondakci M, Gorol M, Willers R, Bilzer T: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Lasers Surg Med 33:75-80, 2003
60. Sakai T, Fujishima I, Sugiyama K, Ryu H, Uemura K: Interstitial laserthermia in neurosurgery. J Clin Laser Med Surg 10:37-40, 1992
61. Schneider JP, Trantakis C, Rubach M, Schulz T, Dietrich J, Winkler D, et al: Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme-a quantitative radiological analysis. Neuroradiology 47:489-500, 2005
62. Schulze PC, Vitzthum HE, Goldammer A, Schneider JP, Schober R: Laser-induced thermotherapy of neoplastic lesions in the brain-underlying tissue alterations, MRI-monitoring and clinical applicability. Acta Neurochir (Wien) 146:803-812, 2004
63. Schwabe B, Kahn T, Harth T, Ulrich F, Schwarzmaier HJ: Laser-induced thermal lesions in the human brain: short- and long-term appearance on MRI. J Comput Assist Tomogr 21:818-825, 1997
64. Schwarzmaier HJ, Eickmeyer F, von Tempelhoff W, Fiedler VU, Niehoff H, Ulrich SD, et al: MR-guided laser irradiation of recurrent glioblastomas. J Magn Reson Imaging 22:799-803, 2005
65. Schwarzmaier HJ, Eickmeyer F, von Tempelhoff W, Fiedler VU, Niehoff H, Ulrich SD, et al: MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. Eur J Radiol 59:208-215, 2006
66. Senft C, Franz K, Blasel S, Oszvald A, Rathert J, Seifert V, et al: Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme. Technol Cancer Res Treat 9:339-346, 2010
67. Sloan AE, Ahluwalia MS, Valerio-Pascua J, Manjila S, Torchia MG, Jones SE, et al: Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma. Clinical article. J Neurosurg 118:1202-1219, 2013
68. Sonntag PD, Hinshaw JL, Lubner MG, Brace CL, Lee FT Jr: Thermal ablation of lung tumors. Surg Oncol Clin N Am 20:369-387, ix, 2011
69. Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, et al: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60:853-860, 2004
70. Stummer W, Nestler U, Stockhammer F, Krex D, Kern BC, Mehdorn HM, et al: Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol 103:361-370, 2011
71. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
72. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
73. Sugiyama K, Sakai T, Fujishima I, Ryu H, Uemura K, Yokoyama T: Stereotactic interstitial laser-hyperthermia using Nd-YAG laser. Stereotact Funct Neurosurg 54-55:501-505, 1990
74. Vaccaro AR, Eck JC: Introduction to best evidence medicine, in Quiñones-Hinojosa A, Raza SM (eds): Controversies in Neuro-Oncology: Best Evidence Medicine for Brain Tumor Surgery. New York: Thieme, 2014, pp 1-8
75. Vredenburgh JJ, Desjardins A, Herndon JE II, Marcello J, Reardon DA, Quinn JA, et al: Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25:4722-4729, 2007
76. Walbert T, Mikkelsen T: Recurrent high-grade glioma: a diagnostic and therapeutic challenge. Expert Rev Neurother 11:509-518, 2011
77. Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 359:492-507, 2008
78. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, et al: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79-88, 2003
79. Westphal M, Ram Z, Riddle V, Hilt D, Bortey E: Gliadel wafer in initial surgery for malignant glioma: long-term followup of a multicenter controlled trial. Acta Neurochir (Wien) 148:269-275, 2006
80. Wick A, Pascher C, Wick W, Jauch T, Weller M, Bogdahn U, et al: Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol 256:734-741, 2009
81. Wolf DS, Laterra J: Salvage therapy for high-grade gliomas, in Quiñones-Hinojosa A, Raza SM (eds): Controversies in Neuro-Oncology: Best Evidence Medicine for Brain Tumor Surgery. New York: Thieme, 2014, pp 97-106
82. Wong ET, Gautam S, Malchow C, Lun M, Pan E, Brem S: Bevacizumab for recurrent glioblastoma multiforme: a metaanalysis. J Natl Compr Canc Netw 9:403-407, 2011